Davida Brenner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Metabolic dysfunction-associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by the condition, and roughly 24% of adults having nonalcoholic fatty liver disease (NAFLD). MASH, previously known as nonalcoholic steatohepatitis or NASH, is a more serious complication of NAFLD, now called metabolic dysfunction-associated steatotic liver disease or MASLD. The nomenclature(op...

Metabolic dysfunction–associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affe

When damaged liver cells are replaced by scar tissue, hepatic fibrosis results. Cirrhosis, liver failure, and even liver cancer can arise as a result of cumulat

Get latest articles and stories on Health at LatestLY. When damaged liver cells are replaced by scar tissue, hepatic fibrosis results. Cirrhosis, liver failure, and even liver cancer can arise as a result of cumulative scarring that, over time, restricts the blood flow to the liver. When the condition is severe, there is no other course of action. Health News | Researchers Discover Causes of Liver Cell Scarring.

Hepatic fibrosis occurs when scar tissue replaces damaged cells in the liver. Over time, accumulating scarring distorts the liver, interferes with its blood supply and may progressively lead to worsening consequences, from cirrhosis to liver failure to liver cancer.